ACE inhibitors and AT1 receptor blockers prevent hyperglycemia-induced oxidative stress by modulating angiotensin action and production; this is of particular interest because hyperglycemia is able to directly modulate cellular angiotensin generation [39]. The gene discussed is AGTR1; the disease is Hyperglycemia.